People
Provention Bio names new senior vice president of Clinical Development
21 August 2019 - Provention Bio Inc (Nasdaq: PRVB), a clinical stage biopharmaceutical company involved in intercepting and preventing immune-mediated diseases, announced yesterday that it has named S...
US FDA approves Celgene's Inrebic
20 August 2019 - The United States Food and Drug Administration (FDA) has approved United States-based Celgene's Inrebic (fedratinib) intended to treat adult patients with intermediate-two or hig...
Series of potent RET kinase inhibitors designed by Xynomic Research Institute
20 August 2019 - Xynomic Research Institute (XRI), a subsidiary of Xynomic Pharmaceuticals Holdings, has designed a series of potent RET kinase inhibitors by computer-assisted drug design, it was repo...
Bioasis Names Dircks as Chief Operating Officer
19 August 2019 - - US-based biopharmaceutical company Bioasis Technology Inc (OTCQB: BIOAF) (TSX.V: BTI) has appointed Caroline Dircks, Ph.D., as chief operating officer, the company said.

Cerevel Therapeutics Names Mishan as Chief Business Officer
16 August 2019 - - US-based neuroscience disease treatements developer Cerevel Therapeutics has appointed Orly Mishan as chief business officer, the company said.

In this newly ...
Marker Therapeutics names new vice president of Regulatory Affairs
16 August 2019 - Marker Therapeutics Inc (Nasdaq:MRKR), a clinical-stage immuno-oncology company specialising in the development of next-generation T cell-based immunotherapies for the treatment of ha...